Filter This View

  • November 19, 2007 | The American Lawyer

    The Firm Reports

    The Firm Reports A-F |

    1 minute read

  • April 9, 2010 | The American Lawyer

    Perrigo Wins Rare Jury Trial in False Advertising Case over Joint Remedy

    It isn't unusual for rival companies to snipe over claims on their products' packaging, but these disputes almost never go to trial. One reason, explains John Villafranco of Kelley Drye & Warren,

    1 minute read

  • March 29, 2010 | The American Lawyer

    Congratulations! If You've Purchased a TV, Computer, or Laptop, You're Probably Now a Member of the Ginormous (and Newly Certified) LCD Antitrust Class

    Yes, it's true. We are all plaintiffs now. Or nearly all of us, thanks to a pair of March 28 orders by San Francisco federal district court judge Susan Illston. Judge Illston certified two classes in

    1 minute read

  • September 20, 2007 | New Jersey Law Journal

    Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)

    Pursuant to Rule 1:28-2, the Trustees of the New Jersey Lawyers' Fund for Client Protection have reported to the Supreme Court the names of those attorneys who have neither made full payment t

    1 minute read

  • December 9, 2004 | The Recorder

    One Way to Settle a Suit: Buy Your Opponent

    The stage was set for a lengthy courtroom battle between Synopsys Inc. and Nassda Corp.But a few weeks before the trial was to begin, the players came up with a new script that put an

    1 minute read

  • July 13, 2010 | The American Lawyer

    California Supreme Court Eliminates Key Antitrust Defense; Pharma Companies to Face Price-Fixing Suit by Pharmacies

    For four decades, California's state antitrust laws have been out of synch with U.S. Supreme Court precedent. California, unlike the federal courts, permitted defendants to argue that direct purchaser

    1 minute read

  • July 11, 2003 | Legal Times

    Arent Fox Looks for Footing on Rough Road

    Arent Fox Kintner Plotkin & Kahn is looking for answers. A longtime fixture of Washington's legal scene, Arent Fox today is beleaguered by flat revenue and a stream of partner ex

    1 minute read

  • Clayworth v. Pfizer, Inc.

    Publication Date: 2010-07-12
    Practice Area:
    Industry:
    Date Filed: 2010-07-12
    Court: Ca. Sup. Ct.
    Judge:
    Attorneys: For plaintiff: Attorneys for Appellant: Alioto Law Firm, Joseph M. Alioto, Joseph M. Alioto, Jr., Theresa D. Moore, Angelina Alioto-Grace, Thomas P. Pier; Law Offices of John H. Boone, John H. Boone; Foreman & Brasso, Russell F. Brasso; Law Offices of James M. Dombroski, James M. Dombroski; Law Offices of Jeffery K. Perkins, Jeffrey K. Perkins; Gary D. McCallister & Associates, Gary D. McCallister, Thomas A. Kelliher, Eric I. Unrein and Jaime Goldstein for Plaintiffs and Appellants. Coughlin Stoia Geller Rudman & Robbins, Pamela M. Parker; Schubert Jonckheer Kolbe & Kralowec and Kimberly A. Kralowec for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiffs and Appellants. Zelle Hofmann Voelbel & Mason, Craig C. Corbitt and Henry A. Cirillo for Pharmacists Planning Services, Inc., as Amicus Curiae on behalf of Plaintiffs and Appellants.
    for defendant: Attorneys for Respondent: Filice Brown Eassa & McLeod, Peter A. Strotz, Paul R. Johnson, William E. Steimle; Davis Polk & Wardwell, Ameila Starr, Arthur F. Golden, William J. Fenrich and Daniel J. Schwartz for Defendant and Respondent AstraZeneca LP. Winston & Strawn, Tyler M. Paetkau, Nicole P. Dogwill, James F. Hurst, Susan A. Pipal, Matthew J. Sullivan; Eimer Stahl Klevorn & Solberg, David M. Stahl, J. Cunyon Gordon and Adam Oyenbanji for Defendant and Respondent Abbott Laboratories. Gibson, Dunn & Crutcher, Jeffrey T. Thomas and James N. Knight for Defendant and Respondent Allergan, Inc. Mayer, Brown, Rowe & Maw, Mayer Brown, Donald M. Falk, John Nadolenco, Mack Anderson; Sheppard Mullin Richter & Hampton, Steven O. Kramer, John P. Stigi III; Hogan & Hartson and Joseph H. Young for Defendant and Respondent Amgen, Inc. Covington & Burling, Elizabeth Abigail Brown, Anita F. Stork, Theodore Voorhees, Jr., and Thomas J. Cosgrove for Defendant and Respondent Boehringer Ingelheim Pharmaceuticals, Inc. Sedgwick, Detert, Moran & Arnold, Paul J. Riehle, Matthew A. Fischer; Cravath, Swaine & Moore, Evan R. Chesler, Elizabeth L. Grayer, Jessica Buturla and Jeffrey B. Korn for Defendant and Respondent Bristol-Myers Squibb Company. Reed Smith, Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer Wolff & Donnelly, Gary Hansen, David Graham and Aaron Mills Scott for Defendant and Respondent Eli Lilly & Company. Irell & Manella, Alexander F. Wiles, John C. Keith; Cleary Gottlieb Steen & Hamilton, George S. Cary, Sara D. Schotland and David I. Gelfand for Defendant and Respondent GlaxoSmithKline PLC. Drinker Biddle & Reath, H. Christian L?Orange, Paul H. Saint-Antoine, Mary E. Kohart, David J. Antczak and Joanne C. Lewers for Defendant and Respondent Hoffmann-La Roche Inc. Folger Levin & Kahn, Crowell & Moring, Beatrice Bich-Dao Nguyen, Samuel Ray Miller, Tracy E. Reichmuth, Cecilia C. Ogbu, Steven E. Wilson; Patterson Belknap Webb & Tyler, William Cavanaugh, Jr., and Cecilia B. Loving for Defendants and Respondents Janssen Pharmaceutica Inc., Johnson & Johnson Health Care Systems, Inc., Ortho Biotech, Inc., and Ortho-McNeil Pharmaceutical, Inc. Hughes Hubbard & Reed, Rita M. Haeusler, John M. Townsend, Scott H. Christensen, James A. Graffam; Orrick, Herrington & Sutcliffe, Robert P. Reznick and David Goldstein for Defendant and Respondent Merck Sharp & Dohme Corp. formerly known as Merck & Co., Inc. Kaye Scholer, Aton Arbisser, Bryant S. Delgadillo, Saul P. Morgenstern, Karin E. Garvey; Faegre & Benson, James A. O?Neal and Kim J. Walker for Defendant and Respondent Novartis Pharmaceuticals Corporation. Nossaman, Gunther, Knox & Elliott, Nossaman, Scott DeVries, Katrina June Lee; Dickstein Shapiro, Peter J. Kadzik, Bernard Nash, Maria Colsey Heard, Milton Marquis and Andres Colin for Defendant and Respondent Pfizer Inc. Latham & Watkins, Charles H. Samel, Jennifer A. Carmassi, Margaret M. Zwisler, Steven H. Schulman and Belinda S. Lee for Defendant and Respondent Pharmaceutical Research and Manufacturers of America. Arnold & Porter, Ronald C. Redcay, Douglas L. Wald, Mark R. Merley, Daniel R. Waldman, Anne P. Davis and Ryan Z. Watts for Defendant and Respondent Wyeth.
    Case Number: No. S166435

    Cite as 10 C.D.O.S. 87895JAMES CLAYWORTH et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Def

  • November 19, 2008 | The American Lawyer

    Samsung Sued Four Times in One Day

    A prominent New York litigator reminded us at lunch yesterday that IP litigation tends to increase during tough times. When profits are hard to come by, he explained, companies suddenly see more clear

    1 minute read

  • May 1, 2010 | Corporate Counsel

    Vested Rights Under Prior Permits Do Not Establish CEQA Baseline

    Communities for a Better Environment v. South Coast Air Quality Management District et al. ___Cal.__) (March 15, 2010; Case No. S161190) In this case, the Supreme Court of Ca

    1 minute read